Sign Up | Log In | What is SocialPicks?

The Standard Register Company (SR) Trade Now » Rate SR - Discuss SR - Add to Watch List

Sector: Consumer/Non-Cyclical > Industry: Office Supplies

SocialPicks Sentiment:

N/A

** not enough data to be rated

This Quarter's Sentiment:

All:

0.0%

Top:

0.0%

Rate SR:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

SR: Bull or Bear?

From: SocialPicks | Blogsphere | All

SocialPicks Community

« previous
« next

From the Blogosphere

Morning Movers 1/09: Palm (PALM) Jumps On Pre Intro; CVS (CVS) Lower On Guidance

StreetInsider.com Morning Movers:

Palm, Inc. (Nasdaq: PALM) 46% HIGHER; Investors cheer Palm Pre. Upgraded at Morgan Joseph

Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX) 36% LOWER; today announced that the first of four Phase 3 trials of its lead investigational product Contrave(R) (naltrexone sustained release (SR)/bupropion SR) met its co-primary and key secondary endpoints, showing a significant reduction in body weight, improvements in markers of cardiovascular risk and reductions in selected food craving measures. Click here for the full report.

<>SYNNEX Corporation (NYSE: SNX) 22% HIGHER;...

Continue reading »

By Street Insider (+16.23% risk: moderate) 01/09/09

Comment

Morning Movers 1/09: Palm (PALM) Jumos On Pre Intro; CVS (CVS) Lower On Guidance

StreetInsider.com Morning Movers:

<>SYNNEX Corporation (NYSE: SNX) 22% HIGHER;...

Continue reading »

By Street Insider (+16.23% risk: moderate) 01/09/09

Comment

After-Hours Movers 1/8: APOL, SABA, SNX, PALM Higher; OREX, HNSN, COH, SCSC Lower

Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX) 36% LOWER; today announced that the first of four Phase 3 trials of its lead investigational product Contrave(R) (naltrexone sustained release (SR)/bupropion SR) met its co-primary and key secondary endpoints, showing a significant reduction in body weight, improvements in markers of cardiovascular risk and reductions in selected food craving measures. Click here for the full report.Hansen Medical, Inc. (NASDAQ: HNSN) 15.7% LOWER; sees Q4 sales of $7.1-$7.4 million, versus the consensus of $12.15million. Apollo Group (Nasdaq: APOL) 8.8% HIGHER; ...

Continue reading »

By Street Insider (+16.23% risk: moderate) 01/08/09

Comment

Quantcast ???? 2000 ?????

N/A

?????? Quantcast ????????????? Founders Fund ? Polaris Venture Partners????? 2000 ????Quantcast ??????? Compete.com ??????????????????????? Widget ????????????????? ??.

Related:

Quantcast ?? Widget ?????? - 14 ?? 2007

Hi5 ?? 2000 ?????? - 23 ?? 2007

Sure-Design Toyota 2000 SR: Futuristische Klassik - 13 November 2007

Triumph TR's? Triumph 2000 Roadster Was the Real Pioneer - 19 December 2007

?????Creative Weblogging, Inc.????????????????????????????

Continue reading »

By HUNG 01/29/08

Comment

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+35.23%	368
2	Gerald Greene	18.14	+70.19%	206
3	stockmarketfunding.com	17.66	+25.78%	53
4	akiralegrand	13.47	+14.32%	60
5	anup2104	12.13	+69.23%	34

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
INTC	Intel Corp
GLD	streetTRACKS Gold
PG	The Procter & Gamble Company
XOM	Exxon Mobil Corp
BIDU	Baiducom Inc ADS
DRYS	DryShips Inc.

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

NPD		NPD - CHINA NEPSTAR POISED FOR SIGNIFICANT GROWTH by penny7
EXAS		EXACT Sciences (NASDAQ: EXAS): Buy and Hold for Long-Term Upside by Mike Havrilla
DNDN		New Global Equity Index to Track Immunotherapy, Vaccine Stocks by Mike Havrilla
BNI		Railroad Stocks Steam Ahead on Buffett’s Buy of BNI by Mike Havrilla
PALM		Pixi and beyond. by aitebar82

... more »

StreetInsider.com on SR

Visit streetinsider.com

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About The Standard Register Company - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.